Get the Stockscreener App
19.80
4.53%
-0.94
After Hours:
19.77
-0.03
-0.15%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $19.80, with a volume of 25.54M.
It is down -4.53% in the last 24 hours and down -6.21% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
See More
Previous Close:
$20.74
Open:
$20.535
24h Volume:
25.54M
Relative Volume:
2.01
Market Cap:
$37.96B
Revenue:
$15.46B
Net Income/Loss:
$1.06B
P/E Ratio:
36.00
EPS:
0.55
Net Cash Flow:
$1.40B
1W Performance:
-8.84%
1M Performance:
-6.21%
6M Performance:
-5.08%
1Y Performance:
-3.88%
1-Day Range:
$19.75
$21.10
1-Week Range:
$19.75
$21.63
52-Week Range:
$17.67
$24.46
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
199 GRANDVIEW ROAD, SKILLMAN
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
19.80 | 37.96B | 15.46B | 1.06B | 1.40B | 0.55 |
|
PG
Procter Gamble Co
|
168.88 | 396.00B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
58.07 | 144.70B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
85.68 | 70.00B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
128.69 | 42.70B | 20.06B | 2.55B | 2.51B | 7.55 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue’s 2024 Financial Performance and 2025 Outlook - TipRanks
Kenvue: Q4 Earnings Snapshot - Milford Mirror
Kenvue (KVUE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Kenvue Inc. (NYSE:KVUE) Shares Acquired by Columbus Macro LLC - MarketBeat
Kenvue Inc. (NYSE:KVUE) Shares Acquired by Golden State Equity Partners - MarketBeat
Robeco Institutional Asset Management B.V. Reduces Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue confirms activist Starboard nominations for board - MSN
Kenvue reports flat 2024 sales - Fashionnetwork USA
China Distribution Disruption Snags Kenvue Results - Citeline News & Insights
Kenvue (KVUE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Kenvue Inc. stock falls Thursday, underperforms market - MarketWatch
Kenvue targets 2%-4% organic sales growth in 2025 with expanded innovations - MSN
Kenvue's Distribution Challenges Pose a Near-Term Threat, but Our Long-Term Outlook Is Favorable - Morningstar
Kenvue's (NYSE:KVUE) Dividend Will Be $0.205 - Simply Wall St
Kenvue Sales Miss Estimates as Weak Volumes Plague Tylenol Maker - MSN
Kenvue (KVUE) Q4 2024 Earnings Call Transcript - AOL
Kenvue's Q4 Sales Miss, Margins Improve - MSN
Kenvue Grapples With Profit Challenges Amid Strong Dollar And Weak Demand - Finimize
Kenvue Reports Nominal Changes in Net Sales for Q4 2024 and Full Year Results - Happi
Kenvue (KVUE) Q4 Earnings Meet Estimates - Yahoo Finance
Kenvue sees 2025 profit below estimates as dollar strengthens - Reuters
Kenvue sees 2025 profit below estimates as dollar strengthens -February 06, 2025 at 07:28 am EST - Marketscreener.com
Kenvue 4Q Sales Fall, 2025 View Misses Market Expectations Amid Forex Headwinds - Marketscreener.com
Kenvue stock slides after missing Q4 estimates By Investing.com - Investing.com South Africa
Kenvue: Q4 Earnings Snapshot -February 06, 2025 at 07:07 am EST - Marketscreener.com
Kenvue stock slides after missing Q4 estimates - Investing.com
Kenvue sees 2025 profit below estimates as strong dollar, weak cough product sales hit - Yahoo Canada Finance
Kenvue Sees 2025 Profit Below Estimates as Dollar Strengthens - U.S News & World Report Money
Kenvue Earnings Reveal Margin Gains Amid Sales Pressure: Key Metrics Decoded - StockTitan
Royal Bank of Canada Reiterates Sector Perform Rating for Kenvue (NYSE:KVUE) - MarketBeat
Yousif Capital Management LLC Trims Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Short Interest in Kenvue Inc. (NYSE:KVUE) Decreases By 8.6% - MarketBeat
Activist Nominates 4 Director Candidates To Kenvue Board - Law360
Starboard nominates four directors to Kenvue's board - MSN
Kenvue confirms activist Starboard nominations for board (KVUE:NYSE) - Seeking Alpha
Is Kenvue Inc. (KVUE) One of the Best Beauty Stocks to Buy According to Hedge Funds? - Insider Monkey
Kenvue Highlights Commitment to Shareholder Value - The Bakersfield Californian
Activist Investor Battle: Starboard Value Takes on Consumer Health Giant Kenvue's Board - StockTitan
Starboard Value nominates four directors to Kenvue board - MSN
Starboard Launches Proxy Fight at Kenvue - The Wall Street Journal
Kenvue Stockholder Starboard Nominates Four Directors -February 05, 2025 at 08:38 am EST - Marketscreener.com
Starboard Value nominates four directors to Kenvue board By Investing.com - Investing.com Canada
Starboard nominates four directors to Kenvue's board By Reuters - Investing.com
Starboard Value Believe Significant Changes To Composition Of Board Of Kenvue Are Necessary - Marketscreener.com
Starboard nominates four directors to Kenvue's board -February 05, 2025 at 07:30 am EST - Marketscreener.com
E. Ohman J or Asset Management AB Acquires New Shares in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Neutrogena® Introduces Tate McRae as Global Brand Ambassador - PR Newswire
Flavin Financial Services Inc. Invests $964,000 in Kenvue Inc. (NYSE:KVUE) - MarketBeat
All It Takes Is $3,000 Invested in Each of These 3 Ultra-Reliable Dividend King Stocks to Help Generate Over $300 in Passive Income in 2025 - The Motley Fool
Renaissance Capital LLC Boosts Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):